Publications found:
512,290
Sort by:
Global Multiple Sclerosis Therapeutic Market Size study, by Drug Class (Immunosuppressants, Immunostimulants, Immunomodulators), Route of Administration (Oral, Injectable [Intramuscular, Intravenous]), Distribution Channel (Hospital, Retail, Online), and Regional Forecasts 2022-2032
US$ 3,000.00
The Global Multiple Sclerosis Therapeutic Market is valued at approximately USD 25.5 billion in 2023 and is projected to grow at a healthy compound annual growth rate of more than 4.70% over the forec...
May 2025
285 pages
Global Myelodysplastic Syndrome Drugs Market Size study, by Drug Type (Hypomethylating, Immune Therapy, Anti-anaemics), Route of Administration (Oral, Parenteral), Medication (Branded, Generic), Cancer Type, Age Group, End-user, and Regional Forecasts 2022-2032
US$ 3,000.00
The Global Myelodysplastic Syndrome (MDS) Drugs Market is valued at approximately USD 2.8 billion in 2023 and is expected to register a robust compound annual growth rate of more than 8.00% over the f...
May 2025
285 pages
Global Naltrexone and Buprenorphine Market Size study, by Product Type (Naltrexone, Buprenorphine, Combination Therapies), by Formulation (Tablets, Injections, Sublingual Films, Extended-Release Solutions), by Indication (Opiate Addiction, Alcohol Dependence, Chronic Pain Management), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032
US$ 3,000.00
Global Naltrexone and Buprenorphine Market is valued approximately at USD 3.74 billion in 2023 and is anticipated to grow with a promising compound annual growth rate of more than 6.99% over the forec...
May 2025
285 pages
Global Non-Injectable Insulin Market Size study, by Product Type (Insulin Patches, Insulin Inhalers, Insulin Pens, Insulin Gels), by Therapeutic Area (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by End User (Hospitals, Home Care Settings, Diabetes Clinics), and Regional Forecasts 2022-2032
US$ 3,000.00
Global Non-Injectable Insulin Market is valued approximately at USD 8.04 billion in 2023 and is anticipated to grow with a steady growth rate of more than 5.67% over the forecast period 2024–2032. As...
May 2025
285 pages
Global Postpartum Health Supplements Market Size study, by Product Type (Single Nutritional [Vitamins, Protein, Omega-3], Combined Nutritional), by Formulation (Capsules, Tablets, Softgels, Liquid), by Distribution Channel (Hospital, Retail, Online) and Regional Forecasts 2022-2032
US$ 3,000.00
Global Postpartum Health Supplements Market is valued approximately at USD 1.2 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.00% over the forecast period 2024-20...
May 2025
285 pages
Global Scopolamine Market Size study, by Dosage Form (Transdermal Patches, Tablets, Injectables), by Application (Motion Sickness, Postoperative Nausea and Vomiting), by Route of Administration (Topical, Oral, Parenteral), Distribution Channel and Regional Forecasts 2022-2032
US$ 3,000.00
Global Scopolamine Market is valued approximately at USD 0.41 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.30% over the forecast period 2024-2032. Scopolamine,...
May 2025
285 pages
Global Subcutaneous Immunoglobulin Market Size study, by Product Type (Intravenous Immunoglobulin, Subcutaneous Immunoglobulin, Hyperimmune Immunoglobulin), by Application (Primary Immunodeficiency, Secondary Immunodeficiency, Inflammatory Diseases, Neurological Disorders), by Administration Route (Subcutaneous, Intravenous), by End Use (Hospitals, Homecare, Specialty Clinics) and Regional Forecasts 2022-2032
US$ 3,000.00
Global Subcutaneous Immunoglobulin Market is valued approximately at USD 11.4 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.76% over the forecast period 2024–203...
May 2025
285 pages
Global Sulphonamides Market Size study, by Route of Administration (Oral, Topical), by Application (Skin Infection, GIT, UTI, RTI), by Medication Type (Generics, Branded), by Distribution Channel (Hospital, Retail, & Online Pharmacies) and Regional Forecasts 2022-2032
US$ 3,000.00
The Global Sulphonamides Market is valued at approximately USD 0.12 billion in 2023 and is projected to grow at a steady compound annual growth rate (CAGR) of 4.80% over the forecast period 2024-2032....
May 2025
285 pages
Global Vaccine Contract Manufacturing Market Size study, by Type (PD-1, PD-L1, CTLA-4), Application (Lung Cancer, Breast Cancer, Bladder Cancer, Melanoma, Cervical Cancer), End-use (Hospitals & Clinics, Cancer Centers), and Regional Forecasts 2022–2032
US$ 3,000.00
The Global Vaccine Contract Manufacturing Market is valued at approximately USD 40.62 billion in 2023 and is anticipated to grow with a robust compound annual growth rate (CAGR) of more than 16.70% ov...
May 2025
285 pages